- Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumorsD P Lindholm
Department of Endocrine Oncology, Uppsala University Hospital, Sweden
Horm Metab Res 43:832-7. 2011..Circulating tumor cells (CTC) have been applied in GEP-NETs quite recently. There is still an unmet need for new markers...
- Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinomaDaniel P Lindholm
Department of Endocrine Oncology, Uppsala University Hospital, 75185 Uppsala, Sweden
Med Oncol 29:301-3. 2012..Temozolomide combined with bevacizumab might be a good treatment option in PDEC, perhaps even in a first-line setting. Prospective studies to answer this are warranted...